diabetic neuropathy. Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetes mellitus with diabetic neuropathy diagnosed by neurologist resident of Yazd controlled glucose (HbA1c less than 9)
Exclusion criteria
Exclusion criteria: Spinal Disorders and Discopathy Heart disorder Renal disorder Liver disorder Active foot ulcer Autoimmune diseases mental illnesses Drug and alcohol addiction Skin diseases in the area of drug use Severe foot vascular disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of peripheral neuropathy. Timepoint: before intervention and 2, 4 , 8 weeks after intervention. Method of measurement: MICHIGAN NEUROPATHY SCREENING INSTRUMENT. | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1c. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: Chromatography (HPLC). | — |
Countries
Iran (Islamic Republic of)
Contacts
Yazd University of Medical Sciences